Rhumbline Advisers Amgen Inc Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025

A detailed history of Rhumbline Advisers transactions in Amgen Inc stock. As of the latest transaction made, Rhumbline Advisers holds 964,835 shares of AMGN stock, worth $275 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
964,835
Previous 979,639 1.51%
Holding current value
$275 Million
Previous $305 Million 11.73%
% of portfolio
0.24%
Previous 0.29%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$262.28 - $309.85 $3.88 Million - $4.59 Million
-14,804 Reduced 1.51%
964,835 $269 Million
Q1 2025

Apr 08, 2025
SELL
$258.59 - $327.36 $5.99 Million - $7.59 Million
-23,183 Reduced 2.31%
979,639 $305 Million
Q4 2024

May 29, 2025
BUY
$258.78 - $328.31 $6 Million - $7.61 Million
23,183 Added 2.37%
1,002,822 $261 Million
Q4 2024

Jan 30, 2025
SELL
$258.78 - $328.31 $3.74 Million - $4.75 Million
-14,456 Reduced 1.42%
1,002,822 $261 Million
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $13.8 Million - $15 Million
-44,449 Reduced 4.19%
1,017,278 $328 Million
Q2 2024

Aug 01, 2024
SELL
$262.75 - $319.31 $51,761 - $62,904
-197 Reduced 0.02%
1,061,727 $332 Million
Q1 2024

May 09, 2024
SELL
$268.87 - $324.56 $617,594 - $745,514
-2,297 Reduced 0.22%
1,061,924 $302 Million
Q4 2023

Feb 08, 2024
BUY
$255.7 - $288.46 $759,429 - $856,726
2,970 Added 0.28%
1,064,221 $307 Million
Q3 2023

Nov 09, 2023
BUY
$218.65 - $271.46 $2.4 Million - $2.98 Million
10,962 Added 1.04%
1,061,251 $285 Million
Q2 2023

Aug 08, 2023
BUY
$214.27 - $253.37 $2.58 Million - $3.05 Million
12,035 Added 1.16%
1,050,289 $233 Million
Q1 2023

May 11, 2023
BUY
$225.79 - $275.2 $8.27 Million - $10.1 Million
36,641 Added 3.66%
1,038,254 $251 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $6.99 Million - $8.88 Million
30,522 Added 3.14%
1,001,613 $263 Million
Q3 2022

Nov 10, 2022
BUY
$224.46 - $253.15 $10.3 Million - $11.6 Million
46,014 Added 4.97%
971,091 $219 Million
Q2 2022

Aug 11, 2022
SELL
$230.71 - $256.74 $4.89 Million - $5.44 Million
-21,198 Reduced 2.24%
925,077 $225 Million
Q1 2022

May 12, 2022
BUY
$219.27 - $242.57 $130,246 - $144,086
594 Added 0.06%
946,275 $229 Million
Q4 2021

Feb 10, 2022
BUY
$198.88 - $227.6 $2.66 Million - $3.05 Million
13,379 Added 1.44%
945,681 $213 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $11.5 Million - $13.4 Million
-54,029 Reduced 5.48%
932,302 $198 Million
Q2 2021

Aug 05, 2021
SELL
$233.58 - $259.14 $12.9 Million - $14.3 Million
-55,094 Reduced 5.29%
986,331 $240 Million
Q1 2021

May 06, 2021
SELL
$221.91 - $258.6 $21.8 Million - $25.4 Million
-98,088 Reduced 8.61%
1,041,425 $259 Million
Q4 2020

Feb 10, 2021
SELL
$216.38 - $257.67 $4.75 Million - $5.66 Million
-21,963 Reduced 1.89%
1,139,513 $262 Million
Q3 2020

Nov 12, 2020
BUY
$234.65 - $260.95 $10.4 Million - $11.5 Million
44,191 Added 3.96%
1,161,476 $295 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $15.9 Million - $19.5 Million
80,302 Added 7.74%
1,117,285 $264 Million
Q1 2020

May 06, 2020
SELL
$182.24 - $241.7 $987,011 - $1.31 Million
-5,416 Reduced 0.52%
1,036,983 $210 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $1.49 Million - $1.91 Million
-7,870 Reduced 0.75%
1,042,399 $251 Million
Q3 2019

Oct 23, 2019
BUY
$174.11 - $208.62 $1.83 Million - $2.2 Million
10,536 Added 1.01%
1,050,269 $203 Million
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $5.43 Million - $6.36 Million
-32,569 Reduced 3.04%
1,039,733 $192 Million
Q1 2019

May 01, 2019
BUY
$180.87 - $203.88 $6.1 Million - $6.87 Million
33,709 Added 3.25%
1,072,302 $204 Million
Q4 2018

Jan 31, 2019
SELL
$178.4 - $208.25 $23.1 Million - $27 Million
-129,554 Reduced 11.09%
1,038,593 $202 Million
Q3 2018

Nov 07, 2018
SELL
$185.29 - $208.89 $15.6 Million - $17.6 Million
-84,029 Reduced 6.71%
1,168,147 $242 Million
Q2 2018

Aug 06, 2018
SELL
$166.05 - $186.51 $11.7 Million - $13.1 Million
-70,381 Reduced 5.32%
1,252,176 $231 Million
Q1 2018

May 02, 2018
SELL
$169.43 - $198.0 $14.9 Million - $17.4 Million
-87,844 Reduced 6.23%
1,322,557 $225 Million
Q4 2017

Feb 09, 2018
BUY
$168.79 - $188.59 $7.79 Million - $8.71 Million
46,167 Added 3.38%
1,410,401 $245 Million
Q3 2017

Nov 06, 2017
BUY
$167.29 - $191.0 $228 Million - $261 Million
1,364,234
1,364,234 $254 Million

Others Institutions Holding AMGN

# of Institutions
3,265
Shares Held
442M
Call Options Held
6.86M
Put Options Held
6.7M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email